Journal article
Disseminated fungal infection in a patient receiving zanubrutinib
Clinical case reports, Vol.11(6), e7564
06/13/2023
DOI: 10.1002/ccr3.7564
PMCID: PMC10264913
PMID: 37323284
Appears in UI Libraries Support Open Access
Abstract
We report a case of fatal disseminated aspergillosis in the setting of administration of zanubrutinib, a second‐generation Bruton's tyrosine kinase inhibitor thought to have a lower rate of immunosuppression‐related side effects.
MRI of the brain and CT angiogram of the chest revealing several lesions suggestive of widespread fungal disease.
Details
- Title: Subtitle
- Disseminated fungal infection in a patient receiving zanubrutinib
- Creators
- Madalyn Walsh - University of IowaAlice Xu - University of Iowa Hospitals and ClinicsZuhair Ballas - University of IowaRolando Sanchez - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Clinical case reports, Vol.11(6), e7564
- DOI
- 10.1002/ccr3.7564
- PMID
- 37323284
- PMCID
- PMC10264913
- NLM abbreviation
- Clin Case Rep
- eISSN
- 2050-0904
- Publisher
- Wiley
- Grant note
- ;
- Language
- English
- Date published
- 06/13/2023
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Immunology; Internal Medicine
- Record Identifier
- 9984430334302771
Metrics
15 Record Views